Clinical Trial Update: SBRT or TACE for Advanced HCC [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing SBRT versus TACE for advanced hepatocellular carcinoma is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University of Aarhus | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN